Madrigal Pharmaceuticals
MDGL
MDGL
31 hedge funds and large institutions have $12.8M invested in Madrigal Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 21 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
76% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 21
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 26
Holders
31
Holding in Top 10
1
Calls
$26K
Puts
$63K
Top Buyers
| 1 | +$1.46M | |
| 2 | +$799K | |
| 3 | +$56.8K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$42K |
| 5 |
JP Morgan Chase
New York
|
+$1K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$104K | |
| 3 | -$98K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$85K |
| 5 |
Millennium Management
New York
|
-$80.8K |